Implementation Guide CH VACD
5.0.0-ci-build - ci-build
Implementation Guide CH VACD
5.0.0-ci-build - ci-build
Implementation Guide CH VACD, published by HL7 Switzerland. This guide is not an authorized publication; it is the continuous build for version 5.0.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7ch/ch-vacd/ and changes regularly. See the Directory of published versions
<Immunization xmlns="http://hl7.org/fhir">
<id value="TCF01-IMMUN2"/>
<meta>
<profile
value="http://fhir.ch/ig/ch-vacd/StructureDefinition/ch-vacd-immunization"/>
</meta>
<text>
<status value="extensions"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: Immunization TCF01-IMMUN2</b></p><a name="TCF01-IMMUN2"> </a><a name="hcTCF01-IMMUN2"> </a><a name="TCF01-IMMUN2-en-US"> </a><p><b>Author of the content</b>: <a href="Patient-TC-patient.html">Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)</a></p><p><b>CH VACD Extension Immunization Medication Reference</b>: <a href="Medication-TC-IMMUN-MEDIC-HAVRIX1440.html">Medication HAVRIX 1440 Inj Susp</a></p><blockquote><p><b>Entry Resource Cross References</b></p><ul><li>entry: Identifier: <code>urn:oid:2.16.756.5.30.1.402.1.3.1.1.1</code>/855bdd69-0a39-4241-b208-9b248a62fb76</li><li>container: Identifier: <a href="http://terminology.hl7.org/5.0.0/NamingSystem-uri.html" title="As defined by RFC 3986 (http://www.ietf.org/rfc/rfc3986.txt)(with many schemes defined in many RFCs). For OIDs and UUIDs, use the URN form (urn:oid:(note: lowercase) and urn:uuid:). See http://www.ietf.org/rfc/rfc3001.txt and http://www.ietf.org/rfc/rfc4122.txt
This oid is used as an identifier II.root to indicate the the extension is an absolute URI (technically, an IRI). Typically, this is used for OIDs and GUIDs. Note that when this OID is used with OIDs and GUIDs, the II.extension should start with urn:oid or urn:uuid:
Note that this OID is created to aid with interconversion between CDA and FHIR - FHIR uses urn:ietf:rfc:3986 as equivalent to this OID. URIs as identifiers appear more commonly in FHIR.
This OID may also be used in CD.codeSystem.">URI</a>/urn:uuid:e2233a2f-d1c2-459d-b4fe-4920c35339e7</li><li>relationcode: replaces</li></ul></blockquote><p><b>identifier</b>: <code>urn:oid:2.16.756.5.30.1.402.1.3.1.1.1</code>/e2233a2f-d1c2-459d-b4fe-4920c35339e7</p><p><b>status</b>: Completed</p><p><b>vaccineCode</b>: <span title="Codes:{http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-swissmedic-cs 558}">Havrix 1440</span></p><p><b>patient</b>: <a href="Patient-TC-patient.html">Monika Wegmueller Female, DoB: 1967-02-10 ( Medical record number)</a></p><p><b>occurrence</b>: 2021-05-27</p><p><b>recorded</b>: 2021-05-27 00:00:00+0200</p><p><b>lotNumber</b>: AHAVB946A</p><p><b>route</b>: <span title="Codes:{http://standardterms.edqm.eu 20035000}">Intramuscular use</span></p><h3>Performers</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Actor</b></td></tr><tr><td style="display: none">*</td><td><a href="PractitionerRole-TC-HCP1-ORG1-ROLE-performer.html">PractitionerRole</a></td></tr></table><p><b>note</b>: Der Patient hat diese Impfung ohne jegliche Nebenwirkungen gut vertragen. (By Practitioner/TC-HCP1-C1 @2021-06-02)</p><h3>ProtocolApplieds</h3><table class="grid"><tr><td style="display: none">-</td><td><b>TargetDisease</b></td><td><b>DoseNumber[x]</b></td></tr><tr><td style="display: none">*</td><td><span title="Codes:{http://snomed.info/sct 40468003}">Viral hepatitis, type A (disorder)</span></td><td>1</td></tr></table></div>
</text>
<extension
url="http://fhir.ch/ig/ch-core/StructureDefinition/ch-ext-author">
<valueReference>🔗
<reference value="Patient/TC-patient"/>
</valueReference>
</extension>
<extension
url="http://fhir.ch/ig/ch-vacd/StructureDefinition/ch-vacd-ext-immunization-medication-reference">
<valueReference>🔗
<reference value="Medication/TC-IMMUN-MEDIC-HAVRIX1440"/>
</valueReference>
</extension>
<extension
url="http://fhir.ch/ig/ch-core/StructureDefinition/ch-core-ext-entry-resource-cross-references">
<extension url="entry">
<valueReference>
<type value="Immunization"/>
<identifier>
<system value="urn:oid:2.16.756.5.30.1.402.1.3.1.1.1"/>
<value value="855bdd69-0a39-4241-b208-9b248a62fb76"/>
</identifier>
</valueReference>
</extension>
<extension url="container">
<valueReference>
<type value="Composition"/>
<identifier>
<system value="urn:ietf:rfc:3986"/>
<value value="urn:uuid:e2233a2f-d1c2-459d-b4fe-4920c35339e7"/>
</identifier>
</valueReference>
</extension>
<extension url="relationcode">
<valueCode value="replaces"/>
</extension>
</extension>
<identifier>
<system value="urn:oid:2.16.756.5.30.1.402.1.3.1.1.1"/>
<value value="e2233a2f-d1c2-459d-b4fe-4920c35339e7"/>
</identifier>
<status value="completed"/>
<vaccineCode>
<coding>
<system
value="http://fhir.ch/ig/ch-vacd/CodeSystem/ch-vacd-swissmedic-cs"/>
<code value="558"/>
<display value="Havrix 1440"/>
</coding>
</vaccineCode>
<patient>🔗
<reference value="Patient/TC-patient"/>
</patient>
<occurrenceDateTime value="2021-05-27"/>
<recorded value="2021-05-27T00:00:00.390+02:00"/>
<lotNumber value="AHAVB946A"/>
<route>
<coding>
<system value="http://standardterms.edqm.eu"/>
<code value="20035000"/>
<display value="Intramuscular use"/>
</coding>
</route>
<performer>
<actor>🔗
<reference value="PractitionerRole/TC-HCP1-ORG1-ROLE-performer"/>
</actor>
</performer>
<note>
<authorReference>🔗
<reference value="Practitioner/TC-HCP1-C1"/>
</authorReference>
<time value="2021-06-02"/>
<text
value="Der Patient hat diese Impfung ohne jegliche Nebenwirkungen gut vertragen."/>
</note>
<protocolApplied>
<targetDisease>
<coding>
<system value="http://snomed.info/sct"/>
<code value="40468003"/>
<display value="Viral hepatitis, type A (disorder)"/>
</coding>
</targetDisease>
<doseNumberPositiveInt value="1"/>
</protocolApplied>
</Immunization>